Injection Pen Market

Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022

Report Code: MD 6041 Feb, 2018, by marketsandmarkets.com

[136 Pages Report] The global injection pen market was valued at USD 29.47 Billion in 2016 and is projected to reach USD 41.38 Billion by 2022, at a CAGR of 6.0% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022.

Objectives of the Study

  • To define, measure, and describe the global injection pen market by type, end user, by therapy, and by region
  • To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of market segments in North America, Europe, Asia Pacific, and RoW
  • To strategically analyze the market structure and profile key players in the global market and comprehensively analyze their core competencies3
  • To track and analyze company developments such as partnerships, agreements, and collaborations; expansions; acquisitions; product approvals; and product launches in the market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global injection pen market and estimate the size of other dependent submarkets. Various secondary sources such as the International Diabetes Federation, World Heart Federation, International Council of Cardiovascular Prevention and Rehabilitation (ICCPR), International Osteoporosis Foundation, Autoimmunity Research Foundation, National Diabetes Services Scheme (NDSS), American Diabetes Association, Statistics Canada, American Association of Diabetes Educators (AADE), American Heart Association, American Autoimmune Related Disease Association, European Association for the Study of Diabetes (EASD), European Society of Endocrinology, European Society of Cardiology, Asian Association for the Study of Diabetes (AASD), ASEAN Federation of Endocrine Societies, Asian Pacific Society of Cardiology, Japan Endocrine Society, Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Diabetes Association (ADJ), Latin American Diabetes Association (ALAD), directories, industry journals, databases, press releases, and annual reports of the companies have been used to identify and collect information useful for the study of this market.

Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

Injection Pen Market

To know about the assumptions considered for the study, download the pdf brochure

The major players in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France), Merck (US), Ypsomed (Switzerland), AstraZeneca (UK), F.Hoffman-La Roche (Switzerland), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland).

Target Audience:

  • Injection pen manufacturing companies
  • Original equipment manufacturing companies
  • Suppliers and distributors of injection pen
  • Healthcare service providers
  • Teaching hospitals and academic medical centers
  • Health insurance players
  • Government bodies/municipal corporations
  • Regulatory bodies
  • Medical research institutes
  • Business research and consulting service providers
  • Venture capitalists
  • Market research and consulting firms

Scope of the Report:

The research report categorizes the market into the following segments and subsegments:

Injection Pen Market, by Type

  • Disposable injection pens
  • Reusable injection pens

Injection Pen Market, by End Users

  • Home care
  • Hospital & clinics

Injection Pen Market, by Therapy

  • Diabetes
    • Insulin
    • GLP-1
  • Growth hormone therapy
  • Fertility
  • Osteoporosis
  • Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer)

Injection Pen Market, by Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Available customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Company Information

  • Detailed analysis and profiling of additional market players (up to 3)

The global injection pen market is projected to reach USD 41.38 Billion by 2022 from USD 30.97 Billion in 2017 at a CAGR of 6.0% during the forecast period. The growth of this market is primarily driven by factors such as the growing prevalence of chronic diseases, increasing number of regulatory approvals, and favorable reimbursement in developed countries, and government support.

The market is segmented on the basis of type, therapy, end user, and region. Based on type, the market is segmented into disposable and reusable injection pens. The disposable injection pens segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the benefits disposable pens offer, such as portability, ease of use, and low possibility of infection.

Based on therapy, the global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies (such as multiple sclerosis, obesity, cardiovascular diseases, rheumatoid arthritis, and migraine). The diabetes segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the large diabetic population across the globe and the favorable reimbursement scenario for diabetes treatments in developed countries.

Based on end user, the global market is categorized into homecare and hospital & clinics. The homecare segment is expected to register the highest CAGR during the forecast period due to the growing demand for self-administration drug delivery devices and the growing prevalence of chronic diseases.

Geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this region can be attributed to the rising prevalence of diabetes, favorable reimbursement scenario, and the increasing number of awareness programs in this region.

Injection Pen Market

Preference for alternative drug delivery modes and poor reimbursement scenario in developing countries is expected to restrain the growth of this market during the forecast period to a certain extent. For instance, in emerging countries such as China and India, no coverage is provided for the home medical devices such as injection pens, thus increasing the out-of-pocket expenditure by patients.

The global injection pens market is dominated by Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France). These players adopted growth strategies such as product launches, mergers & acquisitions, and expansions to maintain and enhance their position in the market. Other prominent players in the market include Ypsomed (Switzerland), Merck (Germany), AstraZeneca (UK), F. Hoffman-la Roche (Switzerland), Becton, Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Design
    2.2 Research Approach
           2.2.1 Secondary Research
           2.2.2 Primary Research
    2.3 Market Size Estimation Methodology
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 33)
    4.1 Global Injection Pen Market Overview
    4.2 Global Market, By Type, 2017 vs 2022
    4.3 Geographic Analysis: Global Market, By Therapy
    4.4 Global Market, By End User, 2017 vs 2022
    4.5 Geographic Snapshot: Global Injection Pen Market

5 Market Overview (Page No. - 37)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Growing Prevalence of Chronic Diseases
                    5.2.1.2 Increasing Number of Regulatory Approvals
                    5.2.1.3 Favorable Reimbursement and Government Support
           5.2.2 Restraints
                    5.2.2.1 Preference for Alternative Drug Delivery Modes
                    5.2.2.2 Poor Reimbursement Scenario in Developing Countries
           5.2.3 Opportunities
                    5.2.3.1 Patent Expiry of Biologics to Drive the Demand for Biosimilars
           5.2.4 Challenges
                    5.2.4.1 Needle-Stick Injuries & Misuse of Injection Pen

6 Injection Pen Market, By Type (Page No. - 42)
    6.1 Introduction
           6.1.1 Disposable Injection Pen
           6.1.2 Reusable Injection Pen

7 Injection Pen Market, By Therapy (Page No. - 46)
    7.1 Introduction
    7.2 Diabetes
           7.2.1 Insulin
           7.2.2 Glucagon-Like Peptide-1 (GLP-1)
    7.3 Growth Hormone Therapy
    7.4 Osteoporosis
    7.5 Fertility
    7.6 Other Therapies

8 Injection Pen Market, By End User (Page No. - 55)
    8.1 Introduction
    8.2 Home Care
    8.3 Hospitals & Clinics

9 Injection Pen Market, By Region (Page No. - 59)
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 UK
           9.3.2 Germany
           9.3.3 France
           9.3.4 Rest of Europe
    9.4 Asia Pacific
           9.4.1 China
           9.4.2 Japan
           9.4.3 India
           9.4.4 RoAPAC
    9.5 RoW

10 Competitive Landscape (Page No. - 94)
     10.1 Overview
     10.2 Market Ranking of OEM Companies
     10.3 Market Share Analysis
     10.4 Competitive Scenario
             10.4.1 Product Launches
             10.4.2 Regulatory Approvals
             10.4.3 Expansions
             10.4.4 Agreements, Collaborations, and Partnerships
             10.4.5 Acquisitions

11 Company Profiles (Page No. - 101)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     11.1 Novo Nordisk
     11.2 Sanofi
     11.3 ELI Lilly and Company
     11.4 Merck
     11.5 Ypsomed
     11.6 Astrazeneca
     11.7 F.Hoffman-La Roche
     11.8 Becton, Dickinson and Company (BD)
     11.9 Owen Mumford
     11.10 Novartis
     11.11 Pfizer
     11.12 Haselmeier

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 129)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details


List of Tables (82 Tables)

Table 1 Injection Pen Market, By Type, 2015–2022 (USD Million)
Table 2 Disposable Market, By Region, 2015–2022 (USD Million)
Table 3 Reusable Market, By Region, 2015–2022 (USD Million)
Table 4 Market, By Therapy, 2015–2022 (USD Million)
Table 5 Market for Diabetes Therapy, By Type, 2015–2022 (USD Million)
Table 6 Injection Pen Market for Diabetes Therapy, By Region, 2015–2022 (USD Million)
Table 7 Market for Insulin Therapy, By Region, 2015–2022 (USD Million)
Table 8 Market for GLP-1 Therapy, By Region, 2015–2022 (USD Million)
Table 9 Market for Growth Hormone Therapy, By Region, 2015–2022 (USD Million)
Table 10 Injection Pen Market for Osteoporosis Therapy, By Region, 2015–2022 (USD Million)
Table 11 Market for Fertility Therapy, By Region, 2015–2022 (USD Million)
Table 12 Market for Other Therapies, By Region, 2015–2022 (USD Million)
Table 13 Market, By End User, 2015–2022 (USD Million)
Table 14 Injection Pen Market for Home Care, By Region, 2015–2022 (USD Million)
Table 15 Market for Hospitals & Clinics, By Region, 2015–2022 (USD Million)
Table 16 Market, By Region, 2015–2022 (USD Million)
Table 17 North America: Market, By Country, 2015–2022 (USD Million)
Table 18 North America: Injection Pen Market, By Type, 2015–2022 (USD Million)
Table 19 North America: Market, By Therapy, 2015–2022 (USD Million)
Table 20 North America: Market for Diabetes Therapy, By Type, 2015–2022 (USD Million)
Table 21 North America: Market, By End User, 2015–2022 (USD Million)
Table 22 Fda Approvals of Injection Pen (2014–2017)
Table 23 US: Market, By Type, 2015–2022 (USD Million)
Table 24 US: Market, By Therapy, 2015–2022 (USD Million)
Table 25 US: Injection Pen Market for Diabetes Therapy, By Type, 2015–2022 (USD Million)
Table 26 US: Market, By End User, 2015–2022 (USD Million)
Table 27 Canada: Market, By Type, 2015–2022 (USD Million)
Table 28 Canada: Market, By Therapy, 2015–2022 (USD Million)
Table 29 Canada: Injection Pen Market for Diabetes Therapy, By Type, 2015–2022 (USD Million)
Table 30 Canada: Market, By End User, 2015–2022 (USD Million)
Table 31 Approvals of Injection Pen (2014–2017)
Table 32 Europe: Market, By Country, 2015–2022 (USD Million)
Table 33 Europe: Market, By Type, 2015–2022 (USD Million)
Table 34 Europe: Injection Pen Market, By Therapy, 2015–2022 (USD Million)
Table 35 Europe: Market for Diabetes Therapy, By Type, 2015–2022 (USD Million)
Table 36 Europe: Injection Pen Market, By End User, 2015–2022 (USD Million)
Table 37 UK: Market, By Type, 2015–2022 (USD Million)
Table 38 UK: Market, By Therapy, 2015–2022 (USD Million)
Table 39 UK: Injection Pen Market for Diabetes Therapy, By Type, 2015–2022 (USD Million)
Table 40 UK: Market, By End User, 2015–2022 (USD Million)
Table 41 Germany: Market, By Type, 2015–2022 (USD Million)
Table 42 Germany: Injection Pen Market, By Therapy, 2015–2022 (USD Million)
Table 43 Germany: Market for Diabetes Therapy, By Type, 2015–2022 (USD Million)
Table 44 Germany: Market, By End User, 2015–2022 (USD Million)
Table 45 France: Market, By Type, 2015–2022 (USD Million)
Table 46 France: Injection Pen Market, By Therapy, 2015–2022 (USD Million)
Table 47 France: Market for Diabetes Therapy, By Type, 2015–2022 (USD Million)
Table 48 France: Injection Pen Market, By End User, 2015–2022 (USD Million)
Table 49 RoE: Market, By Type, 2015–2022 (USD Million)
Table 50 RoE: Market, By Therapy, 2015–2022 (USD Million)
Table 51 RoE: Market for Diabetes Therapy, By Type, 2015–2022 (USD Million)
Table 52 RoE: Injection Pen Market, By End User, 2015–2022 (USD Million)
Table 53 Asia Pacific: Market, By Country, 2015–2022 (USD Million)
Table 54 Asia Pacific: Market, By Type, 2015–2022 (USD Million)
Table 55 Asia Pacific: Market, By Therapy, 2015–2022 (USD Million)
Table 56 Asia Pacific: Injection Pen Market for Diabetes Therapy, By Type, 2015–2022 (USD Million)
Table 57 Asia Pacific: Market, By End User, 2015–2022 (USD Million)
Table 58 China: Market, By Type, 2015–2022 (USD Million)
Table 59 China: Market, By Therapy, 2015–2022 (USD Million)
Table 60 China: Injection Pen Market for Diabetes Therapy, By Type, 2015–2022 (USD Million)
Table 61 China: Market, By End User, 2015–2022 (USD Million)
Table 62 Japan: Market, By Type, 2015–2022 (USD Million)
Table 63 Japan: Market, By Therapy, 2015–2022 (USD Million)
Table 64 Japan: Injection Pen Market for Diabetes Therapy, By Type, 2015–2022 (USD Million)
Table 65 Japan: Market, By End User, 2015–2022 (USD Million)
Table 66 India: Market, By Type, 2015–2022 (USD Million)
Table 67 India: Market, By Therapy, 2015–2022 (USD Million)
Table 68 India: Injection Pen Market for Diabetes Therapy, By Type, 2015–2022 (USD Million)
Table 69 India: Market, By End User, 2015–2022 (USD Million)
Table 70 RoAPAC: Market, By Type, 2015–2022 (USD Million)
Table 71 RoAPAC: Market, By Therapy, 2015–2022 (USD Million)
Table 72 RoAPAC: Injection Pen Market for Diabetes Therapy, By Type, 2015–2022 (USD Million)
Table 73 RoAPAC: Market, By End User, 2015–2022 (USD Million)
Table 74 RoW: Market, By Type, 2015–2022 (USD Million)
Table 75 RoW: Market, By Therapy, 2015–2022 (USD Million)
Table 76 RoW: Market for Diabetes Therapy, By Type, 2015–2022 (USD Million)
Table 77 RoW: Injection Pen Market, By End User, 2015–2022 (USD Million)
Table 78 Product Launches (2014-2017)
Table 79 Regulatory Approvals
Table 80 Expansions
Table 81 Agreements and Partnerships
Table 82 Acquisitions


List of Figures (40 Figures)

Figure 1 Research Design: Global Injection Pen Market
Figure 2 Global Market: Research Methodology Steps
Figure 3 Sampling Frame: Primary Insights
Figure 4 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Primary Sources
Figure 6 Key Industry Insights
Figure 7 Market Size Estimation Methodology: Bottom-Up Approach
Figure 8 Market Size Estimation Methodology: Top-Down Approach
Figure 9 Data Triangulation Methodology
Figure 10 Disposable Injection Pen Dominated the Market in 2017
Figure 11 Diabetes Segment Dominated the Injection Pen Market, By Therapy (2017)
Figure 12 Insulin Segment Dominated the Global Market for Diabetes, By Type (2017)
Figure 13 Home Care Segment Dominated the Market, By End User (2017)
Figure 14 North America is Slated to Witness the Highest Market Growth During the Forecast Period
Figure 15 Growing Prevalence of Chronic Diseases, Increasing Number of Regulatory Approvals, and Favorable Reimbursement and Government Support are Driving Market Growth
Figure 16 Disposable Injection Pen Segment Dominated the Market in 2017
Figure 17 Diabetes Therapy Dominated the Global Injection Pen Market in 2017
Figure 18 Home Care Accounted for the Largest Market Share in 2017
Figure 19 Asia Pacific to Witness the Highest Growth Rate During the Forecast Period
Figure 20 Market, By Type, 2017 vs 2022 (USD Million)
Figure 21 Injection Pen Market, By Therapy, 2017 vs 2022 (USD Million)
Figure 22 Market, By End User, 2017 vs 2022 (USD Million)
Figure 23 North America to Command the Largest Market Share in 2017
Figure 24 North America: Market Snapshot
Figure 25 Europe: Market Snapshot
Figure 26 Asia Pacific: Market Snapshot
Figure 27 RoW: Market Snapshot
Figure 28 Global Injection Pen Market Ranking By OEM Companies (As of 2016)
Figure 29 Market Share, By Key Player, 2016
Figure 30 Strategies Adopted By Market Players (2014–2017)
Figure 31 Novo Nordisk: Company Snapshot (2016)
Figure 32 Sanofi: Company Snapshot (2016)
Figure 33 ELI Lilly and Company: Company Snapshot (2016)
Figure 34 Merck: Company Snapshot (2016)
Figure 35 Ypsomed: Company Snapshot (2016)
Figure 36 Astrazeneca: Company Snapshot (2016)
Figure 37 F.Hoffman-La Roche: Company Snapshot (2016)
Figure 38 BD: Company Snapshot (2016)
Figure 39 Novartis: Company Snapshot (2016)
Figure 40 Pfizer: Company Snapshot (2016)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 6041
Published ON
Feb, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Injection Pen Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved